Drug · DIN 02568853
GABAPENTIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 8, 2026.
- Drug Identification Number (DIN)
- 02568853
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Gabapentin N02BF01
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GABAPENTIN | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 8, 2026: NOC 37676Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named GABAPENTIN
- DIN 02246314 · Marketed
- DIN 02246315 · Marketed
- DIN 02246316 · Marketed
- DIN 02353245 · Marketed
- DIN 02353253 · Marketed
- DIN 02353261 · Marketed
- DIN 02388200 · Marketed
- DIN 02388219 · Marketed
- DIN 02431289 · Marketed
- DIN 02432072 · Marketed
- DIN 02432080 · Marketed
- DIN 02238671 · Cancelled Pre Market
- DIN 02238672 · Cancelled Pre Market
- DIN 02238673 · Cancelled Pre Market
- DIN 02273853 · Cancelled Post Market
- DIN 02304775 · Cancelled Post Market
- DIN 02304783 · Cancelled Post Market
- DIN 02304791 · Cancelled Post Market
- DIN 02342650 · Cancelled Pre Market
- DIN 02342669 · Cancelled Pre Market